Page last updated: 2024-10-22

acetohydroxamic acid and Chronic Disease

acetohydroxamic acid has been researched along with Chronic Disease in 1 studies

acetohydroxamic acid: urease inhibitor
oxime : Compounds of structure R2C=NOH derived from condensation of aldehydes or ketones with hydroxylamine. Oximes from aldehydes may be called aldoximes; those from ketones may be called ketoximes.
N-hydroxyacetimidic acid : A carbohydroximic acid consisting of acetimidic acid having a hydroxy group attached to the imide nitrogen.
acetohydroxamic acid : A member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffith, DP1
Gleeson, MJ1
Lee, H1
Longuet, R1
Deman, E1
Earle, N1

Trials

1 trial available for acetohydroxamic acid and Chronic Disease

ArticleYear
Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi.
    European urology, 1991, Volume: 20, Issue:3

    Topics: Adult; Aged; Bacteriuria; Chronic Disease; Double-Blind Method; Female; Humans; Hydroxamic Acids; Ma

1991